Abstract
We developed an easy-to-use method for genotyping Toxoplasma gondii isolates in a single multiplex PCR assay with 15 microsatellite markers. This method was validated by testing 26 reference isolates that had been characterized with other sets of markers.
The commonly used multilocus methods for genotyping Toxoplasma gondii strains employ PCR-restriction fragment length polymorphism (PCR-RFLP) analysis at 10 markers (16), sequencing at 8 introns of 5 loci (14), and length polymorphism analysis of 5 microsatellite (MS) markers (4). Advantages and disadvantages of these different markers have been reviewed elsewhere (16). Based on our experience within the Toxoplasma Biological Resource Center (BRC ToxoBS) and the National Reference Center for Toxoplasmosis, it appears that screening of a large number of clinical isolates for T. gondii strain typing should rely on an easy-to-use method with two different levels of discrimination. The first step of discrimination is the performed at the typing level: that is, employing the ability of markers to distinguish the major clonal lineages from atypical strains. In areas with a marked clonal population structure such as Europe, the genetic screening of clinical isolates should rapidly identify basic type II or III strains, which represent the majority of isolates, and atypical strains, which are the exception to the rule (3, 11). In this context, the identification of atypical strains is of clinical and epidemiological importance because atypical strains are usually associated with severe disease outcomes and contamination of individuals by non-European strains either during residence abroad or after consumption of imported meat (5, 9, 10). The second level of discrimination is the fingerprinting level, representing a high degree of discriminatory power for differentiating closely related strains belonging to the same lineage. This high-resolution analysis is required for identifying laboratory contaminations for diagnosis issues and for establishing a common source of infection among different infected individuals in an outbreak (7, 8).
Microsatellite (MS) sequences are tandem repeats of short (1 to 6 bp) DNA motifs that are ubiquitous in eukaryotic genomes and undergo length changes due to insertion or deletion of one or multiple repeat units. The most commonly proposed mutation mechanism for MS sequences is strand slippage, occurring predominantly during replication (13). The numbers of repeat motifs differ in a population, thereby creating multiple alleles at an MS locus. MS loci are amplified by PCR using fluorescently labeled forward and unlabeled reverse primers. The dye-labeled products are separated by size using automated electrophoresis and identified by fluorescence detection. We previously designed a multiplex PCR assay with 5 MS markers that were able to reach the typing level but not the fingerprinting level of discrimination between strains (4). Here we developed an easy-to-use and rapid genotyping method which aimed to ensure both levels of genetic discrimination of T. gondii isolates in a single multiplex PCR assay using 15 MS markers located on 11 different chromosomes of T. gondii. In MS sequences with dinucleotide motifs, those with [TG/AC]n and [TC/AG]n repeats are known to exhibit lower mutability than those with [TA/AT]n repeats (13). Eight MS markers with a repeat motif consisting of [TG/AC]n or [TC/AG]n were used as typing markers: five markers (TUB2, W35, TgM-A, B18, and B17) were described in our previous report of a multiplex assay (4), M33 was developed by others (6), and two markers (IV.1 and XI.1) were designed for this study. Seven MS markers with a repeat motif consisting of [TA/AT]n were used as fingerprinting markers: five markers (N60, N82, AA, N61, and N83) were described by us in a previous study (2) whereas M48 and M102 were developed by others (6). For some markers, primers sequences were redesigned to allow PCR amplification and allele size discrimination in the multiplex assay. Chromosome locations and primer sequences for the 15 MS markers are listed in Table 1. Primers were synthesized by Applied Biosystems (Courtabœuf, France). PCR was carried out in a 25-μl reaction mixture consisting of 12.5 μl of 2× Qiagen multiplex PCR Master Mix (Qiagen, France) and 5 pmol each primer. The volumes of DNA template were 1 μl for DNA extracted from tachyzoites in cell culture or mouse ascitic fluid, 3 μl for DNA extracted from bradyzoites in mouse brain, and 5 μl for DNA extracted directly from clinical samples. Cycling conditions were 15 min at 95°C; 30 s at 94°C, 3 min at 61°C, and 30 s at 72°C (35 cycles); and 30 min at 60°C. PCR products were diluted in deionized formamide as follows: 1/20 for DNA extracted from tachyzoites in cell culture or mouse ascitic fluid, 1/10 for DNA extracted from bradyzoites in mouse brain, and 1/2 for DNA extracted directly from clinical samples. One microliter of each diluted PCR product was mixed with 0.5 μl of a dye-labeled size standard (ROX 500; Applied Biosystems) and 23.5 μl of deionized formamide. This mixture was denatured at 95°C for 5 min and then electrophoresed using an automatic sequencer (ABI PRISM 3130xl; Applied Biosystems). The sizes of the alleles in base pairs were estimated using GeneMapper analysis software (version 4.0; Applied Biosystems) (Fig. 1).
TABLE 1.
Microsatellite markers and PCR primers used for the multiplex PCR assay
| Marker | Chromosome (position)a | Repeat motif(s) | Primer sequenceb | Size range (bp) |
|---|---|---|---|---|
| TUB2 | IX (974608 to 974896) | [TG/AC]n | (F) 5′ 6-FAM-GTCCGGGTGTTCCTACAAAA 3′ | 287-291 |
| (R) 5′ TTGGCCAAAGACGAAGTTGT 3′ | ||||
| W35 | II (633241 to 633482) | [TC/AG]n, [TG/AC]n | (F) 5′ HEX-GGTTCACTGGATCTTCTCCAA 3′ | 242-248 |
| (R) 5′ AATGAACGTCGCTTGTTTCC 3′ | ||||
| TgM-A | X (4824879 to 4825083) | [TG/AC]n | (F) 5′ HEX-GGCGTCGACATGAGTTTCTC 3′ | 203-211 |
| (R) 5′ TGGGCATGTAAATGTAGAGATG 3′ | ||||
| B18 | VIIa (2921536 to 2921693) | [TG/AC]n | (F) 5′ 6-FAM-TGGTCTTCACCCTTTCATCC 3′ | 156-170 |
| (R) 5′ AGGGATAAGTTTCTTCACAACGA 3′ | ||||
| B17 | XII (6474746 to 6475079) | [TC/AG]n | (F) 5′ HEX-AACAGACACCCGATGCCTAC 3′ | 334-366 |
| (R) 5′ GGCAACAGGAGGTAGAGGAG 3′ | ||||
| M33 | IV (672591 to 672760) | [TC/AG]n | (F) 5′ 6-FAM- TACGCTTCGCATTGTACCAG 3′ | 165-173 |
| (R) 5′ TCTTTTCTCCCCTTCGCTCT 3′ | ||||
| IV.1 | IV (742419 to 742693) | [TG/AC]n | (F) 5′ HEX-GAAGTTCGGCCTGTTCCTC 3′ | 272-282 |
| (R) 5′ TCTGCCTGGAAAAGGAAAGA 3′ | ||||
| XI.1 | XI (189702 to 190058) | [TG/AC]n | (F) 5′ 6-FAM-GCGTGTGACGAGTTCTGAAA 3′ | 354-362 |
| (R) 5′ AAGTCCCCTGAAAAGCCAAT 3′ | ||||
| M48 | Ia (332951 to 333166) | [TA/AT]n | (F) 5′ 6-FAM-AACATGTCGCGTAAGATTCG 3′ | 209-243 |
| (R) 5′ CTCTTCACTGAGCGCCTTTC 3′ | ||||
| M102 | VIIa (3093491 to 3093664) | [TA/AT]n | (F) 5′ NED-CAGTCCAGGCATACCTCACC 3′ | 164-196 |
| (R) 5′ CAATCCCAAAATCCCAAACC 3′ | ||||
| N60 | Ib (1766079 to 1766221) | [TA/AT]n | (F) 5′ NED-GAATCGTCGAGGTGCTATCC 3′ | 132-157 |
| (R) 5′ AACGGTTGACCTGTGGCGAGT 3′ | ||||
| N82 | XII (1621472 to 1621585) | [TA/AT]n | (F) 5′ HEX-TGCGTGCTTGTCAGAGTTC 3′ | 105-145 |
| (R) 5′ GCGTCCTTGACATGCACAT 3′ | ||||
| AA | VIII (5836880 to 5837144) | [TA/AT]n | (F) 5′ NED-GATGTCCGGTCAATTTTGCT 3′ | 251-332 |
| (R) 5′ GACGGGAAGGACAGAAACAC 3′ | ||||
| N61 | VIIb (4217145 to 4217238) | [TA/AT]n | (F) 5′ 6-FAM-ATCGGCGGTGGTTGTAGAT 3′ | 79-123 |
| (R) 5′ CCTGATGTTGATGTAAGGATGC 3′ | ||||
| N83 | X (1772898 to 1773209) | [TA/AT]n | (F) 5′ 6-FAM-ATGGGTGAACAGCGTAGACA 3′ | 306-338 |
| (R) 5′ GCAGGACGAAGAGGATGAGA 3′ |
Based on position within each chromosome of strain ME49 as given in the Toxo DB website (http://toxodb.org).
(F), forward primer; (R), reverse primer. In each pair of primers, the forward primer was labeled at the 5′ end with flurorescein: 6-carboxyfluorescein (6-FAM) for MS TUB2, XI.1, B18, N83, N61, M33, and M48, hexachlorofluorescein (HEX) for MS TgM-A, B17, N82, W35, and IV.1, and 2,7′,8′-benzo-5′-fluoro-2′,4,7-trichloro-5-carboxyfluorescein (NED) for MS AA, N60, and M102.
FIG. 1.
Electrophoresis of the 15-microsatellite multiplex PCR amplification products from strain P89 by the use of an automatic sequencer and GeneMapper software. The x axis indicates a size fragment scale (in base pairs). The y axis indicates a peak height scale corresponding to the fluorescence intensities of detected peaks.
We used the 15-MS multiplex assay to genotype 26 reference isolates that had been extensively characterized with other sets of markers. These strains have been classified either into the three main clonal lineages (types I, II, and III as classified by PCR-RFLP markers, corresponding to haplogroups 1, 2, and 3 as classified by intron sequencing, respectively) or into atypical genotypes by PCR-RFLP markers corresponding to haplogroups 4 to 11 by intron sequencing (Table 2). The genotyping results of the 15-MS multiplex assay showed that the 8 typing markers (TUB2, W35, TgM-A, B18, B17, M33, IV.1, and XI.1) could readily distinguish clonal types I, II, and III from all the atypical genotypes (Table 2). In each of clonal lineages I to III or haplogroups 1 to 3, representative strains had uniform typing patterns, except for one for lineage II, where allele 244 at marker W35 was identified for isolate BOU. Such variants within clonal lineage II have also been previously determined at the Apico locus with PCR-RFLP markers (17). Atypical isolates were characterized by a different mix of alleles of haplogroups 1 to 3 and by additional atypical alleles at some loci. The detection of atypical alleles by the MS markers underscores the ability of these markers to capture the genetic diversity of highly divergent strains such as South American strains (1, 14, 15). The 7 fingerprinting markers (M48, M102, N60, N82, AA, N61, and N83) provided enhanced genetic resolution, beyond the typing level, in distinguishing closely related isolates within one clonal lineage or haplogroup (Table 2). The Simpson's index of diversity (D) (2) was maximal (D = 1), since all reference isolates had a unique genotype as classified with the 15 MS markers.
TABLE 2.
Genotyping results of 26 reference strains with 15 MS markers in a single multiplex PCR assay
| Type (haplogroup)a | Isolateb | Origin (host)c | Microsatellite marker |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TUB2 | W35 | TgM-A | B18 | B17 | M33 | IV.1 | XI.1 | M48 | M102 | N60 | N82 | AA | N61 | N83 | |||
| I (1) | P | France (H) | 291 | 248 | 209 | 160 | 342 | 169 | 274 | 358 | 209 | 166 | 145 | 121 | 267 | 87 | 308 |
| I (1) | CT1 | USA (cow) | 291 | 248 | 209 | 160 | 342 | 169 | 274 | 358 | 209 | 168 | 145 | 119 | 265 | 87 | 306 |
| I (1) | GIL | France (H) | 291 | 248 | 209 | 160 | 342 | 169 | 274 | 358 | 209 | 166 | 147 | 119 | 265 | 87 | 306 |
| I (1) | BK | Netherlands (H) | 291 | 248 | 209 | 160 | 342 | 169 | 274 | 358 | 209 | 166 | 145 | 119 | 265 | 87 | 316 |
| II (2) | NTE | Germany (H) | 289 | 242 | 207 | 158 | 336 | 169 | 274 | 356 | 221 | 176 | 140 | 113 | 269 | 103 | 310 |
| II (2) | PTG | USA (sheep) | 289 | 242 | 207 | 158 | 336 | 169 | 274 | 356 | 215 | 174 | 142 | 111 | 265 | 91 | 310 |
| II (2) | BOU | France (H) | 289 | 244 | 207 | 158 | 336 | 169 | 274 | 356 | 213 | 178 | 140 | 113 | 259 | 99 | 310 |
| III (3) | CTG | USA (cat) | 289 | 242 | 205 | 160 | 336 | 165 | 278 | 356 | 215 | 190 | 147 | 111 | 269 | 89 | 312 |
| III (3) | NED | France (H) | 289 | 242 | 205 | 160 | 336 | 165 | 278 | 356 | 209 | 190 | 147 | 111 | 267 | 91 | 312 |
| III (3) | M7741 | USA (sheep) | 289 | 242 | 205 | 160 | 336 | 165 | 278 | 356 | 215 | 190 | 147 | 111 | 267 | 91 | 312 |
| III (3) | VEG | USA (H) | 289 | 242 | 205 | 160 | 336 | 165 | 278 | 356 | 213 | 188 | 153 | 111 | 267 | 89 | 312 |
| Atypical (4) | MAS | France (H) | 291 | 242 | 205 | 162 | 362 | 169 | 272 | 358 | 221 | 166 | 142 | 111 | 332 | 95 | 338 |
| Atypical (4) | CASTELLS | Uruguay (sheep) | 287 | 242 | 207 | 158 | 358 | 169 | 274 | 356 | 239 | 164 | 138 | 109 | 283 | 87 | 324 |
| Atypical (4) | TgCatBr1 | Brazil (cat) | 289 | 242 | 205 | 160 | 342 | 165 | 278 | 358 | 233 | 164 | 147 | 111 | 316 | 89 | 308 |
| Atypical (5) | GUY-KOE | Fr. Guiana (H) | 289 | 246 | 203 | 160 | 337 | 165 | 274 | 356 | 209 | 172 | 136 | 111 | 251 | 109 | 310 |
| Atypical (5) | GUY-MAT | Fr. Guiana (H) | 291 | 242 | 203 | 160 | 339 | 165 | 272 | 358 | 221 | 174 | 138 | 107 | 277 | 95 | 312 |
| Atypical (5) | RUB | Fr. Guiana (H) | 289 | 242 | 205 | 170 | 360 | 167 | 274 | 356 | 223 | 190 | 142 | 109 | 259 | 85 | 312 |
| Atypical (6) | GPHT | France (H) | 291 | 248 | 205 | 160 | 342 | 165 | 274 | 354 | 229 | 166 | 147 | 111 | 283 | 91 | 306 |
| Atypical (6) | BOF | Belgium (H) | 291 | 248 | 205 | 160 | 342 | 165 | 274 | 354 | 227 | 166 | 147 | 111 | 273 | 89 | 306 |
| Atypical (7) | CAST | USA (H) | 291 | 242 | 205 | 158 | 342 | 167 | 276 | 356 | 211 | 168 | 147 | 119 | 279 | 87 | 306 |
| Atypical (8) | TgCatBr5 | Brazil (cat) | 291 | 242 | 205 | 160 | 362 | 165 | 278 | 356 | 237 | 174 | 140 | 111 | 265 | 89 | 314 |
| Atypical (9) | P89 | USA (pig) | 291 | 242 | 205 | 160 | 348 | 165 | 278 | 356 | 213 | 190 | 142 | 111 | 261 | 87 | 314 |
| Atypical (9) | TgCatBr3 | Brazil (cat) | 289 | 242 | 205 | 160 | 348 | 165 | 278 | 356 | 213 | 190 | 142 | 111 | 263 | 113 | 312 |
| Atypical (10) | VAND | Fr. Guiana (H) | 291 | 242 | 203 | 162 | 344 | 167 | 276 | 356 | 217 | 170 | 142 | 113 | 277 | 91 | 308 |
| Atypical (10) | GUY-DOS | Fr. Guiana (H) | 289 | 246 | 203 | 160 | 344 | 167 | 272 | 356 | 229 | 176 | 142 | 113 | 263 | 85 | 312 |
| Atypical (11) | COUGAR | Canada (cougar) | 289 | 242 | 205 | 158 | 336 | 169 | 274 | 354 | 219 | 174 | 151 | 119 | 259 | 79 | 332 |
The types were defined by analysis of single nucleotide polymorphisms at 5 or 10 PCR-RFLP markers (12, 17); the haplogroups were defined by analysis of sequence polymorphisms within 8 introns of five unlinked loci (14).
Strain P is also known as strain PT; strain PTG is a clone of the ME49 strain; strain CTG is also known as strain CEP or C; strains GUY-KOE, GUY-MAT, and GUY-DOS are also known as strains GUY-2002-KOE, GUY-2002-MAT, and GUY-2001-DOS, respectively; strain P89 is also known as strain TgPgUs15; strain COUGAR is also known as strain TgCgCa1 or COUG.
Fr. Guiana, French Guiana; H, human; UK, United Kingdom; USA, United States.
The association of the 15 MS markers with different mutability patterns enabled two different levels of genetic resolution for differentiating T. gondii strains at the typing level (types I, II, and III versus atypical strains) and at the fingerprinting level (closely related isolates within a clonal lineage). Multilocus sequence-based typing is the best tool for estimating the true rate of DNA polymorphism in phylogenetic studies, but the increased cost and investment of time makes that method unsuitable for genetic screening of a large number of isolates. PCR-RFLP markers are preferred tools for the latter purpose, but their low resolution level makes them inadequate for distinguishing genetically closely related strains. The 15-MS multiplex assay is therefore the best available tool to reveal whether two isolates are genetically identical or different, i.e., to identify a common source of infection in an outbreak, a laboratory contamination, and mixed infections. The limitations of this assay are the requirement for the availability of an automated sequencer and the sensitivity of the method, which has been estimated by testing serial dilutions of RH strain tachyzoites to be between 50 to 100 T. gondii genome equivalents per 5 μl of DNA sample. Testing this method on samples with lower DNA concentrations is not recommended because of incomplete amplification of markers or difficulties in interpreting the results due to overlaps of microsatellite peaks with nonspecific PCR products. Compared with other genotyping methods, the sensitivity appears similar to that reported with intron sequencing. PCR-RFLP analysis can detect as few as 10 T. gondii genome equivalents per PCR, but such a threshold of detection is reached only by nested PCR assays (16). We did not develop a nested PCR assay for improving the sensitivity of our 15-MS multiplex assay since, in our experience, double-round PCR amplification using this method represents too high a risk of PCR contamination and often leads to misleading results.
Acknowledgments
We thank Jitender Dubey, David Sibley, and Chunlei Su for kindly providing DNA samples from reference strains. We are indebted to the following members of the network of the Toxoplasma Biological Resource Center for providing T. gondii isolates from human cases of toxoplasmosis: Sahar Albaba, Dominique Aubert, Jacques Berthonneau, Marie-Hélène Bessières, Rachida Boukhari, Marie-Pierre Brenier-Pinchart, Bernard Carme, Sophie Cassaing, Bernard Cimon, Bernard Couprie, Bernadette Cuisenier, Laurence Delhaes, Magalie Demar, Nicole Desbois, Chantal Duhamel, Than-Hai Duong, Loïc Favennec, Denis Filisetti, Pierre Flori, Jacqueline Franck, Hélène Fricker-Hidalgo, Françoise Gay-Andrieu, Catherine Kauffmann-Lacroix, Marie Machouart, Pierre Marty, Jean Menotti, Gilles Nevez, Luc Paris, Hervé Pelloux, Christelle Pomares, Francine Pratlong, Dorothée Quinio, Florence Robert-Gangneux, Philippe Thulliez, Anne Totet, Nathalie Van Langendonck, Isabelle Villena, and Hélène Yera.
Footnotes
Published ahead of print on 29 September 2010.
REFERENCES
- 1.Ajzenberg, D., A. L. Banuls, C. Su, A. Dumètre, M. Demar, B. Carme, and M. L. Dardé. 2004. Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int. J. Parasitol. 34:1185-1196. [DOI] [PubMed] [Google Scholar]
- 2.Ajzenberg, D., A. L. Banuls, M. Tibayrenc, and M. L. Dardé. 2002. Microsatellite analysis of Toxoplasma gondii shows considerable polymorphism structured into two main clonal groups. Int. J. Parasitol. 32:27-38. [DOI] [PubMed] [Google Scholar]
- 3.Ajzenberg, D., N. Cogné, L. Paris, M. H. Bessières, P. Thulliez, D. Filisetti, H. Pelloux, P. Marty, and M. L. Dardé. 2002. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J. Infect. Dis. 186:684-689. [DOI] [PubMed] [Google Scholar]
- 4.Ajzenberg, D., A. Dumètre, and M. L. Dardé. 2005. Multiplex PCR for typing strains of Toxoplasma gondii. J. Clin. Microbiol. 43:1940-1943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ajzenberg, D., H. Yera, P. Marty, L. Paris, F. Dalle, J. Menotti, D. Aubert, J. Franck, M. H. Bessières, D. Quinio, H. Pelloux, L. Delhaes, N. Desbois, P. Thulliez, F. Robert-Gangneux, C. Kauffmann-Lacroix, S. Pujol, M. Rabodonirina, M. E. Bougnoux, B. Cuisenier, C. Duhamel, T. H. Duong, D. Filisetti, P. Flori, F. Gay-Andrieu, F. Pratlong, G. Nevez, A. Totet, B. Carme, H. Bonnabau, M. L. Dardé, and I. Villena. 2009. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J. Infect. Dis. 199:1155-1167. [DOI] [PubMed] [Google Scholar]
- 6.Blackston, C. R., J. P. Dubey, E. Dotson, C. Su, P. Thulliez, D. Sibley, and T. Lehmann. 2001. High-resolution typing of Toxoplasma gondii using microsatellite loci. J. Parasitol. 87:1472-1475. [DOI] [PubMed] [Google Scholar]
- 7.Carme, B., D. Ajzenberg, M. Demar, S. Simon, M. L. Dardé, B. Maubert, and B. de Thoisy. 2009. Outbreaks of toxoplasmosis in a captive breeding colony of squirrel monkeys. Vet. Parasitol. 163:132-135. [DOI] [PubMed] [Google Scholar]
- 8.Demar, M., D. Ajzenberg, D. Maubon, F. Djossou, D. Panchoe, W. Punwasi, N. Valery, C. Peneau, J. L. Daigre, C. Aznar, B. Cottrelle, L. Terzan, M. L. Dardé, and B. Carme. 2007. Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects. Clin. Infect. Dis. 45:e88-e95. [DOI] [PubMed] [Google Scholar]
- 9.De Salvador-Guillouët, F., D. Ajzenberg, S. Chaillou-Opitz, M. C. Saint-Paul, B. Dunais, P. Dellamonica, and P. Marty. 2006. Severe pneumonia during primary infection with an atypical strain of Toxoplasma gondii in an immunocompetent young man. J. Infect. 53:e47-e50. [DOI] [PubMed] [Google Scholar]
- 10.Elbez-Rubinstein, A., D. Ajzenberg, M. L. Dardé, R. Cohen, A. Dumètre, H. Yera, E. Gondon, J. C. Janaud, and P. Thulliez. 2009. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J. Infect. Dis. 199:280-285. [DOI] [PubMed] [Google Scholar]
- 11.Halos, L., A. Thebault, D. Aubert, M. Thomas, C. Perret, R. Geers, A. Alliot, S. Escotte-Binet, D. Ajzenberg, M. L. Dardé, B. Durand, P. Boireau, and I. Villena. 2010. An innovative survey underlining the significant level of contamination by Toxoplasma gondii of ovine meat consumed in France. Int. J. Parasitol. 40:193-200. [DOI] [PubMed] [Google Scholar]
- 12.Howe, D. K., and L. D. Sibley. 1995. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis. 172:1561-1566. [DOI] [PubMed] [Google Scholar]
- 13.Kelkar, Y. D., S. Tyekucheva, F. Chiaromonte, and K. D. Makova. 2008. The genome-wide determinants of human and chimpanzee microsatellite evolution. Genome Res. 18:30-38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Khan, A., B. Fux, C. Su, J. P. Dubey, M. L. Dardé, J. W. Ajioka, B. M. Rosenthal, and L. D. Sibley. 2007. Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome. Proc. Natl. Acad. Sci. U. S. A. 104:14872-14877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Pena, H. F., S. M. Gennari, J. P. Dubey, and C. Su. 2008. Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int. J. Parasitol. 38:561-569. [DOI] [PubMed] [Google Scholar]
- 16.Su, C., E. K. Shwab, P. Zhou, X. Q. Zhu, and J. P. Dubey. 2010. Moving towards an integrated approach to molecular detection and identification of Toxoplasma gondii. Parasitology 137:1-11. [DOI] [PubMed] [Google Scholar]
- 17.Su, C., X. Zhang, and J. P. Dubey. 2006. Genotyping of Toxoplasma gondii by multilocus PCR-RFLP markers: a high resolution and simple method for identification of parasites. Int. J. Parasitol. 36:841-848. [DOI] [PubMed] [Google Scholar]

